Modulation of hypoxia-inducible factor-1 alpha in cultured primary cells by intracellular ascorbate

Free Radical Biology and Medicine

Volumn 42, Issue 6, 2007, Pages 765-772

  Vissers, Margret C M ^a   Gunningham, Sarah P ^a   Morrison, Mary J ^a   Dachs, Gabi U ^a   Currie, Margaret J ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Ascorbate; Cultured cells; GLUT 1 expression; Hypoxic response; VEGF; Vitamin C

Indexed keywords

ASCORBIC ACID; ASPARAGINE HYDROXYLASE; MESSENGER RNA; OXYGENASE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROXYLATION; INTRACELLULAR TRANSPORT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STABILITY; SKIN FIBROBLAST; TRANSCRIPTION REGULATION; UMBILICAL VEIN;

ANOXIA; ASCORBIC ACID; BLOTTING, WESTERN; CELL LINE, TUMOR; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FIBROBLASTS; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORTER TYPE 1; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33847051180     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2006.11.023     Document Type: Article

References (55)

1. Wenger R.H. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J. 16 (2002) 1151-1162
2. Lando D., Gorman J.J., Whitelaw M.L., and Peet D.J. Oxygen-dependent regulation of hypoxia-inducible factors by prolyl and asparaginyl hydroxylation. Eur. J. Biochem. 270 (2003) 781-790
3. Masson N., and Ratcliffe P.J. HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels. J. Cell Sci. 116 (2003) 3041-3049
4. Marx J. Cell biology. How cells endure low oxygen. Science 303 (2004) 1454-1456
5. Kaelin W.G. Proline hydroxylation and gene expression. Annu. Rev. Biochem. 74 (2005) 115-128
6. Maxwell P.H., Dachs G.U., Gleadle J.M., Nicholls L.G., Harris A.L., Stratford I.J., Hankinson O., Pugh C.W., and Ratcliffe P.J. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc. Natl. Acad. Sci. USA. 94 (1997) 8104-8109
7. Dachs G.U., Patterson A.V., Firth J.D., Ratcliffe P.J., Townsend K.M., Stratford I.J., and Harris A.L. Targeting gene expression to hypoxic tumor cells. Nat. Med. 3 (1997) 515-520
8. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev., Cancer 3 (2003) 721-732
9. Hopfl G., Ogunshola O., and Gassmann M. HIFs and tumors-Causes and consequences. Am. J. Physiol., Regul. Integr. Comp. Physiol. 286 (2004) R608-R623
10. Park J.W., Chun Y.S., and Kim M.S. Hypoxia-inducible factor 1-related diseases and prospective therapeutic tools. J. Pharmacol. Sci. 94 (2004) 221-232
11. Schofield C.J., and Ratcliffe P.J. Oxygen sensing by HIF hydroxylases. Nat. Rev., Mol. Cell Biol. 5 (2004) 343-354
12. Hirsila M., Koivunen P., Gunzler V., Kivirikko K.I., and Myllyharju J. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J. Biol. Chem. 278 (2003) 30772-30780
13. Mole D.R., Maxwell P.H., Pugh C.W., and Ratcliffe P.J. Regulation of HIF by the von Hippel-Lindau tumour suppressor: implications for cellular oxygen sensing. IUBMB Life 52 (2001) 43-47
14. Lee C., Kim S.J., Jeong D.G., Lee S.M., and Ryu S.E. Structure of human FIH-1 reveals a unique active site pocket and interaction sites for HIF-1 and von Hippel-Lindau. J. Biol. Chem. 278 (2003) 7558-7563
15. Lando D., Peet D.J., Gorman J.J., Whelan D.A., Whitelaw M.L., and Bruick R.K. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16 (2002) 1466-1471
16. Linke S., Stojkoski C., Kewley R.J., Booker G.W., Whitelaw M.L., and Peet D.J. Substrate requirements of the oxygen-sensing asparaginyl hydroxylase factor-inhibiting hypoxia-inducible factor. J. Biol. Chem. 279 (2004) 14391-14397
17. Knowles H.J., Raval R.R., Harris A.L., and Ratcliffe P.J. Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. Cancer Res. 63 (2003) 1764-1768
18. Jones D.T., Trowbridge I.S., and Harris A.L. Effects of transferrin receptor blockade on cancer cell proliferation and hypoxia-inducible factor function and their differential regulation by ascorbate. Cancer Res. 66 (2006) 2749-2756
19. Banhegyi G., Braun L., Csala M., Puskas F., and Mandl J. Ascorbate metabolism and its regulation in animals. Free Radic. Biol. Med. 23 (1997) 793-803
20. Levine M. New concepts in the biology and biochemistry of ascorbic acid. N. Engl. J. Med. 314 (1986) 892-902
21. Tsao C.S. An overview of ascorbic acid chemistry and biochemistry. In: Packer L., and Fuchs J. (Eds). Vitamin C in Health and Disease (1997), Dekker, New York 25-58
22. Ek A., Strom K., and Cotgreave I.A. The uptake of ascorbic acid into human umbilical vein endothelial cells and its effect on oxidant insult. Biochem. Pharmacol. 50 (1995) 1339-1346
23. Leist M., Raab B., Maurer S., Rosick U., and Brigelius-Flohe R. Conventional cell culture media do not adequately supply cells with antioxidants and thus facilitate peroxide-induced genotoxicity. Free Radic. Biol. Med. 21 (2001) 297-306
24. Knowles H.J., Mole D.R., Ratcliffe P.J., and Harris A.L. Normoxic stabilization of hypoxia-inducible factor-1alpha by modulation of the labile iron pool in differentiating U937 macrophages: effect of natural resistance-associated macrophage protein 1. Cancer Res. 66 (2006) 2600-2607
25. Vissers M.C.M., Pullar J.M., and Hampton M.B. Hypochlorous acid causes caspase activation and apoptosis or growth arrest in human endothelial cells. Biochem. J. 344 (1999) 443-449
26. Jaffe E., Nachman R.L., Becker C.G., and Minick C.R. Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J. Clin. Invest. 52 (1973) 2745-2756
27. Vile G.F., Rothwell L.A., and Kettle A.J. Hypochlorous acid activates the tumor suppressor protein p53 in cultured human skin fibroblasts. Arch. Biochem. Biophys. 359 (1998) 51-56
28. Vile G.F., Rothwell L.A., and Kettle A.J. Initiation of rapid, p53-dependent growth arrest in cultured human skin fibroblasts by reactive chlorine species. Arch. Biochem. Biophys. 377 (2000) 122-128
29. May J.M. How does ascorbic acid prevent endothelial dysfunction?. Free Radic. Biol. Med. 28 (2000) 1421-1429
30. Karp S., Ciambra C.M., and Miklean S. High-performance liquid chromatographic post-column reaction system for the electrochemical detection of ascorbic acid and dehydroascorbic acid. J. Chromatogr. 504 (1990) 434-440
31. Vissers M.C.M., Lee W.-G., and Hampton M.B. Regulation of apoptosis by vitamin C: Specific protection of the apoptotic machinery against exposure to chlorinated oxidants. J. Biol. Chem. 276 (2001) 46835-46840
32. Dall'Asta V., Rossi P.A., Bussolati O., and Gazzola G.C. Response of human fibroblasts to hypertonic stress. Cell shrinkage is counteracted by an enhanced active transport of neutral amino acids. J. Biol. Chem. 269 (1994) 10485-10491
33. Hillebrand U., Hausberg M., Stock C., Shahin V., Nikova D., Riethmuller C., Kliche K., Ludwig T., Schillers H., Schneider S.W., and Oberleithner H. 17Beta-estradiol increases volume, apical surface and elasticity of human endothelium mediated by Na+/H+ exchange. Cardiovasc. Res. 69 (2006) 916-924
34. Cassel D., Whiteley B., Zhuang Y.X., and Glaser L. Mitogen-independent activation of Na+/H+ exchange in human epidermoid carcinoma A431 cells: regulation by medium osmolarity. J. Cell. Physiol. 122 (1985) 178-186
35. Hornig D. Distribution of ascorbic acid, metabolites and analogues in man and animals. Ann. N. Y. Acad. Sci. 258 (1975) 103-118
36. Bergsten P., Amitai G., Kehrl J., Dhariwal K.R., Klein H.G., and Levine M. Millimolar concentrations of ascorbic acid in purified human mononuclear leukocytes. Depletion and reaccumulation. J. Biol. Chem. 265 (1990) 2584-2587
37. Butler J.D., Bergsten P., Welch R.W., and Levine M. Ascorbic acid accumulation in human skin fibroblasts. Am. J. Clin. Nutr. 54 (1991) 1144S-1146S
38. Kaufman S. Coenzymes and hydroxylases: ascorbate and dopamine-beta-hydroxylase; tetrahydropteridines and phenylalanine and tyrosine hydroxylases. Pharmacol. Rev. 18 (1966) 61-69
39. Kivirikko K.I., and Myllyharju J. Prolyl 4-hydroxylases and their protein disulfide isomerase subunit. Matrix Biol. 16 (1998) 357-368
40. Miller R.L., Elsas L.J., and Priest R.E. Ascorbate action on normal and mutant human lysyl hydroxylases from cultured dermal fibroblasts. J. Invest. Dermatol. 72 (1979) 241-247
41. Myllyla R., Gunzler V., Kivirikko K.I., and Kaska D.D. Modification of vertebrate and algal prolyl 4-hydroxylases and vertebrate lysyl hydroxylase by diethyl pyrocarbonate. Evidence for histidine residues in the catalytic site of 2-oxoglutarate-coupled dioxygenases. Biochem. J. 286 Pt 3 (1992) 923-927
42. Salnikow K., Donald S.P., Bruick R.K., Zhitkovich A., Phang J.M., and Kasprzak K.S. Depletion of intracellular ascorbate by the carcinogenic metals nickel and cobalt results in the induction of hypoxic stress. J. Biol. Chem. 279 (2004) 40337-40344
43. Lu H., Dalgard C.L., Mohyeldin A., McFate T., Tait A.S., and Verma A. Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. J. Biol. Chem. 280 (2005) 41928-41939
44. Chen Q., Fischer A., Reagan J.D., Yan L.J., and Ames B.N. Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc. Natl. Acad. Sci. USA. 92 (1995) 4337-4341
45. Dachs G.U., and Tozer G.M. Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation. Eur. J. Cancer 36 (2000) 1649-1660
46. Goldenberg H., and Schweinzer E. Transport of vitamin C in animal and human cells. J. Bioenerg. Biomembr. 26 (1994) 359-367
47. Vera J.C., Rivas C.I., Zhang R.H., Farber C.M., and Golde D.W. Human HL-60 myeloid leukemia cells transport dehydroascorbic acid via the glucose transporters and accumulate reduced ascorbic acid. Blood 84 (1994) 1628-1634
48. Kuo S.M., Tan C.H., Dragan M., and Wilson J.X. Endotoxin increases ascorbate recycling and concentration in mouse liver. J. Nutr. 135 (2005) 2411-2416
49. Pullar J.M., Vissers M.C.M., and Winterbourn C.C. Glutathione oxidation by hypochlorous acid in endothelial cells produces glutathione sulfonamide as a major product but not glutathione disulfide. J. Biol. Chem. 276 (2001) 22120-22125
50. Pullar J.M., Winterbourn C.C., and Vissers M.C.M. Loss of GSH and thiol enzymes in endothelial cells exposed to sublethal concentrations of hypochlorous acid. Am. J. Physiol. 277 (1999) H1505-H1512
51. Rivabene R., Viora M., Matarrese P., Rainaldi G., D'Ambrosio A., and Malorni W. N-acetyl-cysteine enhances cell adhesion properties of epithelial and lymphoid cells. Cell Biol. Int. 19 (1995) 681-686
52. Mizukami Y., Li J., Zhang X., Zimmer M.A., Iliopoulos O., and Chung D.C. Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancer. Cancer Res. 64 (2004) 1765-1772
53. Mizukami Y., Fujiki K., Duerr E.M., Gala M., Jo W.S., Zhang X., and Chung D.C. Hypoxic regulation of vascular endothelial growth factor through the induction of phosphatidylinositol 3-kinase/Rho/ROCK and c-Myc. J. Biol. Chem. 281 (2006) 13957-13963
54. Stolze I.P., Mole D.R., and Ratcliffe P.J. Regulation of HIF: prolyl hydroxylases. Novartis Found. Symp. 272 (2006) 15-25 (discussion 25-36)
55. Salnikow K., and Kasprzak K.S. Ascorbate depletion: a critical step in nickel carcinogenesis?. Environ. Health Perspect. 113 (2005) 577-584